Federal Register / Vol. 63, No. 131 /Thursday, July 9, 1998 / Notices 37117

Alpine, Texas, and thereby indirectly

acquire Alpine Delaware Financial

Corporation, Dover, Delaware, and First

National Bank in Alpine, Alpine, Texas.

Board of Governors of the Federal Reserve

System, July 6, 1998.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 98–18282 Filed 7–8–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Notice of Proposals to Engage in

Permissible Nonbanking Activities or

to Acquire Companies that are

Engaged in Permissible Nonbanking

Activities

The companies listed in this notice

have given notice under section 4 of the

Bank Holding Company Act (12 U.S.C.

1843) (BHC Act) and Regulation Y, (12

CFR Part 225) to engage de novo, or to

acquire or control voting securities or

assets of a company, including the

companies listed below, that engages

either directly or through a subsidiary or

other company, in a nonbanking activity

that is listed in § 225.28 of Regulation

Y (12 CFR 225.28) or that the Board has

determined by Order to be closely

related to banking and permissible for

bank holding companies. Unless

otherwise noted, these activities will be

conducted throughout the United States.

Each notice is available for inspection

at the Federal Reserve Bank indicated.

The notice also will be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether the proposal complies

with the standards of section 4 of the

BHC Act.

Unless otherwise noted, comments

regarding the applications must be

received at the Reserve Bank indicated

or the offices of the Board of Governors

not later than July 24, 1998.

A. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. Northern Trust Corporation,

Chicago, Illinois; to engage de novo

through its subsidiary, Northern Trust

Bank, Federal Savings Bank, Bloomfield

Hills, Michigan (in organization), and

thereby engage in the operation of a

savings association, pursuant to §

225.28(b)(4)(ii) of Regulation Y.

Board of Governors of the Federal Reserve

System, July 6, 1998.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 98–18281 Filed 7–8–98; 8:45 am]

BILLING CODE 6210–01–F

GENERAL SERVICES

ADMINISTRATION

[OMB Control No. 3090–0043]

Submission for OMB Review;

Comment Request Entitled Appraisal,

Fair Annual Rental for Parking Spaces

AGENCY: Public Buildings Service, GSA.

ACTION: Notice of request for an

extension to an existing OMB clearance

(3090–0043).

SUMMARY: Under the provisions of the

Paperwork Reduction Act of 1995 (44

U.S.C. Chapter 35), the Office of

Acquisition Policy has submitted to the

Office of Management and Budget

(OMB) a request to review and approve

an extension of a previously approved

information collection requirement

concerning Appraisal, Fair Annual

Rental for Parking Spaces.

DATES: Comment Due Date: September

8, 1998.

ADDRESSES: Comments regarding this

burden estimate or any other aspect of

this collection of information, including

suggestions for reducing this burden,

should be submitted to: Edward

Springer, GSA Desk Officer, Room 3235,

NEOB, Washington, DC 20503, and to

Marjorie Ashby, General Services

Administration (MVP), 1800 F Street

NW, Washington, DC 20405.

FOR FURTHER INFORMATION CONTACT:

William C. Wyrick, Public Buildings

Service (202) 501–4407.

SUPPLEMENTARY INFORMATION:

A. Purpose

The GSA is requesting the Office of

Management and Budget (OMB) to

review and approve information

collection, 3090–0043, concerning

Appraisal, Fair Annual Rental for

Parking Spaces. This form is needed by

contract and staff appraisers to estimate

the assessed parking rates for agencies

occupying space in Federal and private

buildings.

B. Annual Reporting Burden

Respondents: 260; annual responses:

1300; average hours per response: 1.6;

burden hours: 2200.

Copy of Proposal: A copy of this

proposal may be obtained from the GSA

Acquisition Policy Division (MVP),

Room 4011, GSA Building, 1800 F

Street, NW, Washington, DC 20405, or

by telephoning (202) 501–3822, or by

faxing your request to (202) 501–3341.

Dated: June 19, 1998.

Ida M. Ustad,

Deputy Associate Administrator, Office of

Acquisition Policy.

[FR Doc. 98–18193 Filed 7–8–98; 8:45 am]

BILLING CODE 6820–61–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 98094]

Measuring the Risk for Transmission

and Sequelae From Chlamydial

Disease in the Era of Amplification

Testing; Notice of Availability of Funds

for Fiscal Year 1998

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1998

funds for a cooperative agreement

program on Chlamydia trachomatis (Ct)

infection in order to enhance strategies

for prevention of STD-related infertility.

Please reference the Attachment for

background information relevant to this

program announcement. This program

addresses the ‘‘Healthy People 2000’’

priority area 19, Sexually Transmitted

Diseases.

The purpose of this research program

is to gain a better understanding of the

risk for Ct disease transmission and

sequelae in the context of new, highly

sensitive diagnostic technologies. When

patient specimens are subjected to both

standard non-amplification tests

(culture, enzyme immunoassay [EIA],

direct fluorescent-antibody [DFA], DNA

hybridization) and highly sensitive

nucleic acid amplification tests such as

the polymerase chain reaction [PCR],

ligase chain reaction [LCR], or

transcription mediated amplification

[TMA], some proportion of patient

specimens will test positive by one

diagnostic measure, and negative by

another. Rarely, a specimen will test

positive by standard non-amplification

tests and negative by more sensitive

tests (+/¥). Much more commonly, a

specimen which is negative by standard

diagnostic testing will test positive by

highly sensitive nucleic acid

amplification tests (¥/+). Such

discordant specimens have usually been

classified as true positives, or false

positives on the basis of a highly

sensitive third confirmatory test

targeting a different portion of the Ct